M10.49
Other secondary gout, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Other secondary gout, classified under ICD-10 code M10.49, is a form of gout that results from underlying health conditions or medications that lead to elevated uric acid levels in the body. Unlike primary gout, which occurs due to inherent metabolic issues, secondary gout is caused by different medical problems that influence uric acid metabolism. It can affect multiple areas of the body, making diagnosis and management more complex. Recognizing the signs and understanding the underlying causes can help in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Chronic kidney disease, which impairs uric acid excretion Use of specific medications such as diuretics, low-dose aspirin, or chemotherapy agents that increase uric acid levels Metabolic syndrome, including obesity, hypertension, and insulin resistance Certain hematologic conditions like leukemia or lymphoma that cause increased cell turnover Excessive alcohol consumption, particularly beer and spirits Diet high in purine-rich foods like red meats, shellfish, and certain fish
Key Symptoms: Swelling, redness, and warmth in affected joints Intense joint pain, often sudden during the night Tenderness and stiffness in multiple affected sites Formation of tophi, which are uric acid crystal deposits under the skin Possible fever during acute attacks Presence of gout attacks in joints such as the knees, ankles, elbows, and wrists
Diagnostic & Treatment
Diagnosis Path: Diagnosis of other secondary gout involves a combination of clinical assessment and laboratory tests. Key diagnostic steps include: - Blood tests to measure serum uric acid levels, which are often elevated but can be normal during acute attacks - Joint fluid analysis, where a sample is extracted and examined for uric acid crystals - Imaging techniques like X-ray, ultrasound, or dual-energy CT scans to detect crystal deposits and joint damage - Evaluation of underlying health conditions that might contribute to hyperuricemia, such as kidney function tests and metabolic assessments
Treatment Protocols: Managing secondary gout involves a multifaceted approach focused on controlling uric acid levels and addressing underlying health issues. Typical interventions include: - Medications to lower uric acid levels, such as allopurinol or febuxostat - Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids to reduce joint inflammation during attacks - Lifestyle modifications, including dietary changes to reduce intake of purine-rich foods and alcohol - Weight management to decrease overall uric acid production - Proper management of underlying medical conditions like kidney disease or metabolic syndrome - Regular monitoring of uric acid levels and joint health to prevent future attacks
Clinical Advice & FAQs
Billing Guidance
Is M10.49 a billable ICD-10 code?
Yes, M10.49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.49?
Clinical documentation must specify the nature of Other secondary gout, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference